AstraZeneca

Pharmalot Ed Silverman

AstraZeneca sues FDA to prevent generic versions of Crestor

Pharmalot Ed Silverman

STAT Plus: Pharmalot, Pharmalittle: Endo may sell assets as reliance on price hikes wanes

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: AstraZeneca takes $80 million hit on ‘ineffective’ flu vaccine

Business Leah Samuel

AstraZeneca plans to scour 2 million genomes for rare disease genes

Pharmalot Ed Silverman

STAT Plus: Pharmalot, Pharmalittle: Valeant looks to sign Perrigo chief as its new CEO

Pharmalot Ed Silverman

STAT Plus: Pharmalot, Pharmalittle: AstraZeneca suffers setback with its blood thinner

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: AstraZeneca reworks executive pay and revenue goals